Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
bioMérieux, a global leader in the research and development services sector, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1963, the company has consistently innovated in the field of in vitro diagnostics, providing essential solutions for clinical and industrial applications.
Specialising in microbiological testing, bioMérieux offers a range of unique products and services, including automated systems and rapid diagnostic tests that enhance patient care and safety. The company is renowned for its commitment to quality and accuracy, positioning itself as a trusted partner in healthcare and food safety.
With numerous accolades and a strong market presence, bioMérieux continues to advance the frontiers of diagnostics, contributing significantly to public health and safety worldwide.
+38 vs industry average
Biomerieux’s score of 71 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
bioMérieux reported total carbon emissions of approximately 1.18 billion kg CO2e in 2024. This included Scope 1 emissions of about 22 million kg CO2e, Scope 2 emissions (market-based) of around 34 million kg CO2e, and Scope 3 emissions of approximately 1.13 billion kg CO2e.
The company has set several climate commitments. bioMérieux is committed to reaching net-zero greenhouse gas emissions across its value chain by 2050, as validated by the Science Based Targets initiative (SBTi).
Near-term SBTi targets include:
Long-term SBTi targets include:
Additionally, bioMérieux aims for 67% of its suppliers, by emissions covering purchased goods and services, fuel and energy related activities, upstream transportation and distribution, business travel, and employee commuting, to have science-based targets by 2026. This data is inherited from its parent company, bioMérieux S.A.
2050
90% reduction in Scope 2
bioMérieux commits to reduce absolute scope 2 GHG emissions 90% by 2050 from a 2019 base year.
2034
63% reduction in Scope 2
bioMérieux commits to reduce absolute scope 2 GHG emissions 63% by 2034 from a 2019 base year.
2050
bioMérieux commits to reduce absolute scope 2 GHG emissions…
bioMérieux commits to reduce absolute scope 2 GHG emissions 63% by 2034 from a 2019 base year.
See all 10 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Biomerieux’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more